An internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality, and clinical research, Dr. Robert Califf now heads the U.S. Food and Drug Administration.
It’s not an unfamiliar job. He also served as FDA commissioner from February 2016 to January 2017.
Califf’s passion for clinical data and patient outcomes led to the creation of the Duke Clinical Research Institute, (DCRI), one of the world’s leading academic clinical research organizations. As the founding director of the DCRI, Califf oversaw and often led many clinical trials in cardiology and other specialties.